With a market cap of $139.4 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company headquartered in New York, known for developing and manufacturing medicines and vaccines across areas such as oncology, immunology, and infectious diseases. Its key products include Comirnaty, Paxlovid, Eliquis, and Ibrance. The pharma titan is slated to announce its fiscal Q3 2025 results before the market opens on Tuesday, Nov. 4. Ahead of the event, analysts predict Pfizer to report an adjusted EPS of$0.68, do ...